BioSpace News Archive

The Danish biotech company, Tetra Pharm Technologies, announces promising results from preclinical testing of its pain-relieving drug - TPT0301.

Charles River Laboratories International, Inc. announced the launch of its off-the-shelf lentiviral vector packaging plasmids, providing a streamlined solution to the challenges associated with plasmid sourcing in cell and gene therapies.

eGenesis, a biotechnology company developing human-compatible organs for the treatment of organ failure, announced the publication of a paper in the journal Nature Communications highlighting novel findings from the largest cohort of long-term non-human primate recipients of porcine kidney xenotransplantation to date.

Orthopedic Care Partners, a leading orthopedic practice management platform, announced a strategic affiliation with the American Spine & Orthopaedic Institute, a renowned practice specializing in complex adult and pediatric spine pathology, based in Orlando, FL.

ViewRay, Inc. announced that the VA Oklahoma City Healthcare System has selected MRIdian MRI-guided radiation therapy system to expand radiation therapy services at the Oklahoma City VA Medical Center.

Salipro Biotech AB, a pioneering biotech company focusing on challenging drug targets for the discovery of next-generation therapeutics, is delighted to announce the issuance of a new patent in Japan for its Salipro® platform technology.

Gritstone bio, Inc. announced that the Compensation Committee of the company’s Board of Directors granted five employees nonqualified stock options to purchase an aggregate of 83,300 shares of its common stock with an exercise price of $2.06, which is equal to the closing price of Gritstone’s common stock on June 2, 2023, the last trading day preceding the day of the approval.

Acumen Pharmaceuticals, Inc. announced that it will present topline results from a Phase 1 trial of its candidate ACU193, the first clinical stage AβO-directed antibody therapy, at the Alzheimer’s Association International Conference 2023 taking place in Amsterdam, Netherlands and online from July 16-20, 2023.

Microbix Biosystems Inc., a life sciences innovator, manufacturer, and exporter announces that it is presenting results of its Quality Assessment Products for supporting the clinical use and accuracy of tests for antimicrobial-resistant sexually-transmitted infections at the ASM Microbe conference of the American Society of Microbiology, taking place in Houston, Texas June 15-19, 2023.

First Wave BioPharma, Inc. announced that it has achieved the enrollment target in its ongoing Phase 2 SPAN clinical trial investigating an enhanced enteric microgranule delivery formulation of adrulipase for the treatment of exocrine pancreatic insufficiency in patients with cystic fibrosis.